Vasyl Vasko

2.2k total citations
38 papers, 1.7k citations indexed

About

Vasyl Vasko is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Vasyl Vasko has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Vasyl Vasko's work include Thyroid Cancer Diagnosis and Treatment (26 papers), Cancer-related Molecular Pathways (12 papers) and Metabolism, Diabetes, and Cancer (7 papers). Vasyl Vasko is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (26 papers), Cancer-related Molecular Pathways (12 papers) and Metabolism, Diabetes, and Cancer (7 papers). Vasyl Vasko collaborates with scholars based in United States, Ukraine and Albania. Vasyl Vasko's co-authors include Motoyasu Saji, Kirk Jensen, Aneeta Patel, Joanna Kłubo-Gwieździńska, Kenneth D. Burman, Matthew D. Ringel, Paul E. Wakely, Michael V. Knopp, Jiachao Liang and Richard T. Kloos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Vasyl Vasko

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasyl Vasko United States 21 882 659 602 293 200 38 1.7k
Aneeta Patel United States 25 876 1.0× 716 1.1× 548 0.9× 278 0.9× 207 1.0× 56 1.7k
Valentina Sancisi Italy 22 489 0.6× 816 1.2× 360 0.6× 290 1.0× 122 0.6× 33 1.5k
Joshua Klopper United States 17 1.5k 1.7× 750 1.1× 580 1.0× 245 0.8× 423 2.1× 34 2.2k
Fatima Rangwala United States 14 421 0.5× 618 0.9× 557 0.9× 159 0.5× 177 0.9× 34 1.6k
Roberto E. Favoni Italy 20 527 0.6× 844 1.3× 541 0.9× 327 1.1× 291 1.5× 39 1.6k
Iñigo Landa United States 24 1.9k 2.1× 1.0k 1.6× 983 1.6× 406 1.4× 602 3.0× 46 3.0k
Françoise Descôtes France 20 213 0.2× 593 0.9× 342 0.6× 326 1.1× 119 0.6× 66 1.2k
Luis J. Leandro‐García Spain 20 315 0.4× 781 1.2× 532 0.9× 476 1.6× 109 0.5× 31 1.5k
Akira Komiya Japan 29 503 0.6× 943 1.4× 438 0.7× 492 1.7× 243 1.2× 99 2.4k
Richeng Jiang China 19 246 0.3× 952 1.4× 600 1.0× 390 1.3× 256 1.3× 48 1.8k

Countries citing papers authored by Vasyl Vasko

Since Specialization
Citations

This map shows the geographic impact of Vasyl Vasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasyl Vasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasyl Vasko more than expected).

Fields of papers citing papers by Vasyl Vasko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasyl Vasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasyl Vasko. The network helps show where Vasyl Vasko may publish in the future.

Co-authorship network of co-authors of Vasyl Vasko

This figure shows the co-authorship network connecting the top 25 collaborators of Vasyl Vasko. A scholar is included among the top collaborators of Vasyl Vasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasyl Vasko. Vasyl Vasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kushchayeva, Yevgeniya, Vasyl Vasko, Kirk Jensen, et al.. (2025). Differentiated Thyroid Cancer in Severe Insulin Resistance. PubMed. 12(4). 229–240. 1 indexed citations
2.
Shobab, Leila, Kirk Jensen, Matthew McCoy, et al.. (2024). Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer. Cancers. 16(7). 1260–1260. 2 indexed citations
3.
Shobab, Leila, Matthew McCoy, Sonam Kumari, et al.. (2024). PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer. Cancers. 16(21). 3632–3632. 2 indexed citations
4.
Thakur, Shilpa, Corina Millo, Craig Cochran, et al.. (2020). 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer. Clinical Cancer Research. 27(5). 1399–1409. 25 indexed citations
5.
6.
Vasko, Vasyl, et al.. (2019). PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer. Frontiers in Endocrinology. 10. 769–769. 25 indexed citations
7.
Thakur, Shilpa, Kelli Gaskins, Vasyl Vasko, et al.. (2018). Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo. Clinical Cancer Research. 24(16). 4030–4043. 108 indexed citations
8.
Jensen, Kirk, Athanasios Bikas, Aneeta Patel, et al.. (2017). Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells. Endocrine Related Cancer. 24(3). 147–156. 27 indexed citations
9.
Bikas, Athanasios, et al.. (2016). Targeted therapies in thyroid cancer: an extensive review of the literature. Expert Review of Clinical Pharmacology. 9(10). 1299–1313. 30 indexed citations
10.
Bikas, Athanasios, Kirk Jensen, Aneeta Patel, et al.. (2015). Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocrine Related Cancer. 22(6). 919–932. 49 indexed citations
11.
Kushchayeva, Yevgeniya, Kirk Jensen, Kenneth D. Burman, & Vasyl Vasko. (2014). Repositioning therapy for thyroid cancer: new insights on established medications. Endocrine Related Cancer. 21(3). R183–R194. 12 indexed citations
12.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, John Costello, et al.. (2012). Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocrine Related Cancer. 19(3). 447–456. 72 indexed citations
13.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, Andrew J. Bauer, et al.. (2012). The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. Journal of Endocrinology. 214(2). 207–216. 17 indexed citations
14.
Jensen, Kirk, Aneeta Patel, Joanna Kłubo-Gwieździńska, Andrew J. Bauer, & Vasyl Vasko. (2011). Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis. Endocrine Related Cancer. 18(5). 613–626. 26 indexed citations
15.
Patel, Aneeta, Joanna Kłubo-Gwieździńska, О. С. Ларін, et al.. (2011). BRAF V600E Mutation Analysis from May-Grünwald Giemsa-Stained Cytological Samples as an Adjunct in Identification of High-Risk Papillary Thyroid Carcinoma. Endocrine Pathology. 22(4). 195–199. 16 indexed citations
16.
Saji, Motoyasu, Xiaoli Zhang, David Jarjoura, et al.. (2010). Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion. Endocrine Related Cancer. 17(4). 989–999. 36 indexed citations
17.
Jensen, Kirk, Aneeta Patel, О. С. Ларін, et al.. (2010). Human herpes simplex viruses in benign and malignant thyroid tumours. The Journal of Pathology. 221(2). 193–200. 26 indexed citations
18.
Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology. 27(10). 1675–1684. 430 indexed citations
19.
Vasko, Vasyl, Andrew J. Bauer, R. Michael Tuttle, & Gary L. Francis. (2007). Papillary and Follicular Thyroid Cancers in Children. Endocrine development. 10. 140–172. 10 indexed citations
20.
Vasko, Vasyl & Motoyasu Saji. (2006). Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Current Opinion in Oncology. 19(1). 11–17. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aneeta Patel Breakdown of academic impact, for papers by Valentina Sancisi Breakdown of academic impact, for papers by Joshua Klopper Breakdown of academic impact, for papers by Fatima Rangwala Breakdown of academic impact, for papers by Roberto E. Favoni Breakdown of academic impact, for papers by Iñigo Landa Breakdown of academic impact, for papers by Françoise Descôtes Breakdown of academic impact, for papers by Luis J. Leandro‐García Breakdown of academic impact, for papers by Akira Komiya Breakdown of academic impact, for papers by Richeng Jiang
Rankless by CCL
2026